OAB-040: BUMEL vs MEL-200 prior autologous transplant for patients with newly diagnosed multiple myeloma previously treated with bortezomib, lenalidomide and dexamethasone: final results of a phase 3 trial

Clinical Lymphoma Myeloma and Leukemia(2022)

引用 0|浏览11
暂无评分
关键词
multiple myeloma,lenalidomide,autologous transplant,bortezomib,dexamethasone
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要